Why didn’t we negatively rank Pfizer $PFE US on the recent CEO Share sale?
Albert Bourla’s sale of $5.5m of stock on the announcement of Pfizer’s Covid-19 vaccine success […]
Why didn’t we negatively rank Pfizer $PFE US on the recent CEO Share sale? Read More